Indications
Therapeutic Asset Ratings
6,305 results matching 1 filter
91,565
assets
·
7,904
sponsors
·
3,128
indications
Methodology v0.2
Filters
1
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
Conteltinib
Malignant Pancreatic Neoplasm
Shouyao Holdings (Beijing) Co. LTD
P1/2
CC
(45)
Cpx-351
Li-Fraumeni Syndrome
Masonic Cancer Center, University of Minnesota
P1/2
CC
(45)
crc01
Diffuse Large B-Cell Lymphoma
Curocell Inc.
P1/2
CC
(45)
crc01
Primary Mediastinal Large B-Cell Lymphoma
Curocell Inc.
P1/2
CC
(45)
Crept-618
Cancer
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
P1/2
CC
(45)
Crizotinib
Cutaneous Melanoma
IDEAYA Biosciences
P1/2
CC
(45)
ct041 autologous car t-cell
Pancreatic Neoplasm
CARsgen Therapeutics Co., Ltd.
P1/2
CC
(45)
CTO1681
Cytokine Release Syndrome
CytoAgents, Inc.
P1/2
CC
(45)
cts2190 capsules
Triple-Negative Breast Carcinoma
CytosinLab Therapeutics Co., Ltd.
P1/2
CC
(45)
cvl006
Cancer
Convalife (Shanghai) Co., Ltd.
P1/2
CC
(45)
Cyclophosphamide
Refractory Precursor T-Lymphoblastic Lymphoma/Leukemia
Princess Maxima Center for Pediatric Oncology
P1/2
CC
(45)
Cytarabine
Refractory Precursor T-Lymphoblastic Lymphoma/Leukemia
Princess Maxima Center for Pediatric Oncology
P1/2
CC
(45)
Cytarabine
Plasmablastic Lymphoma
AIDS Malignancy Consortium
P1/2
CC
(45)
Cytokine-Treated Veto Cells
Myeloproliferative Neoplasm
M.D. Anderson Cancer Center
P1/2
CC
(45)
Daraxonrasib
Cancer
Revolution Medicines, Inc.
P1/2
CC
(45)
Darovasertib
Cutaneous Melanoma
IDEAYA Biosciences
P1/2
CC
(45)
Dasatinib
Precursor B-Cell Acute Lymphoblastic Leukemia
Princess Maxima Center for Pediatric Oncology
P1/2
CC
(45)
Dasatinib
Refractory Precursor T-Lymphoblastic Lymphoma/Leukemia
Princess Maxima Center for Pediatric Oncology
P1/2
CC
(45)
db-1310
Cancer
Synnovation Therapeutics, Inc.
P1/2
CC
(45)
Dcsz11
Head And Neck Squamous Cell Carcinoma
West China Hospital
P1/2
CC
(45)
Decitabine
Cutaneous Melanoma
Roswell Park Cancer Institute
P1/2
CC
(45)
Decitabine
Precursor B-Cell Acute Lymphoblastic Leukemia
Princess Maxima Center for Pediatric Oncology
P1/2
CC
(45)
Decitabine
Refractory Precursor T-Lymphoblastic Lymphoma/Leukemia
Princess Maxima Center for Pediatric Oncology
P1/2
CC
(45)
Decitabine
Neoplasm
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
P1/2
CC
(45)
Decoy20
Colorectal Cancer
Indaptus Therapeutics, Inc
P1/2
CC
(45)
Showing 3076 to 3100 of 6,305 assets
Previous
Page 124 of 253
Next